5.790USD-4.77%Mkt Cap: 314.14M USDP/E: —Last update: 2026-06-01
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinan…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap314.14M USD
Enterprise Value271.64M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-32.77M USD
Revenue/Share—
Last Price5.790 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees35
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.81
PEG—
EV/EBITDA-7.40
EV/Revenue—
P/S—
P/B6.83
EPS (TTM)-0.71
EPS (Forward)-0.88
52W Range
3.47533% of range10.42
52W High10.42 USD
52W Low3.475 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-58.39%
ROA-53.39%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.06M USD
CapEx (TTM)40.00K USD
FCF Margin—
FCF Yield-5.73%
Net Debt-51.12M USD
Net Debt/EBITDA1.39
Balance Sheet
Debt/Equity0.00
Current Ratio9.11
Quick Ratio8.98
Book Value/Sh0.8770 USD
Cash/Share0.9530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 15, 2018
Splits
Last Split1:20
Split DateNov 15, 2018
Analyst Consensus
Rating—
Target (Mean)15.50 USD
Target Range11.00 USD – 25.00 USD
# Analysts4
Ownership
Shares Out.53.88M
Float28.60M
Insiders27.74%
Institutions37.77%
Short Interest
Short Ratio30.5d
Short % Float13.40%
Short % Out.8.99%
Shares Short4.84M
Short (prev mo.)4.77M
Technical
SMA 506.388 (-9.4%)
SMA 2007.177 (-19.3%)
Beta0.99
S&P 52W Chg27.94%
Avg Vol (30d)150.25K
Avg Vol (10d)145.16K
Technical Indicators
RSI (14)47.4
MACD-0.1146
MACD Signal-0.1512
MACD Hist.+0.0367
BB Upper6.681 USD
BB Middle6.126 USD
BB Lower5.571 USD
BB Width18.11%
ATR (14)0.3447 USD
Vol Ratio (20d)0.72x